Sarepta Therapeutics, Inc. (SRPT)
18.90
-0.23
(-1.20%)
USD |
NASDAQ |
May 13, 11:36
Sarepta Therapeutics Free Cash Flow : 91.18M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| PTC Therapeutics, Inc. | -516.78M |
| Keros Therapeutics, Inc. | 105.95M |
| REGENXBIO, Inc. | -126.38M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Cytokinetics, Inc. | -548.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -202.68M |
| Cash from Investing (Quarterly) | -134.39M |
| Cash from Financing (Quarterly) | 0.241M |
| Free Cash Flow Per Share (Quarterly) | -1.688 |
| Free Cash Flow to Equity (Quarterly) | -202.88M |
| Free Cash Flow to Firm (Quarterly) | -184.82M |
| Free Cash Flow Yield | 4.45% |